Trial Profile
Effect of Ursodeoxycholic Acid or Ursodeoxycholic Acid Combined with Losartan for Treatment of Non-Alcoholic Steatohepatitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2014
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Ursodeoxycholic acid
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 20 May 2014 New trial record
- 11 Apr 2014 Results presented at the 49th Annual Meeting of the European Association for the Study of the Liver.